Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Jun;75(11):5416-20.
doi: 10.1128/JVI.75.11.5416-5420.2001.

Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice

Affiliations
Comparative Study

Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice

B Liang et al. J Virol. 2001 Jun.

Abstract

Nasal immunoglobulin A provides an initial defense against inhaled respiratory pathogens. However, it is not known whether the nasal-associated lymphoid tissues (NALT) are able to mount an effective long-lasting pathogen-specific immune response, nor is it known whether functional differences exist between the organized NALT (O-NALT) and the diffuse NALT lining the nasal passages (D-NALT). Here we show that although both the O-NALT and the D-NALT are capable of producing virus-specific antibody in response to influenza virus infection, the frequency of specific antibody-forming cells in the D-NALT is much greater than the frequency observed in the O-NALT. Furthermore, we show that the D-NALT but not the O-NALT is the site of long-term virus-specific humoral immunity which lasts for the life of the animal. These results indicate that the D-NALT is not only the major effector site of the NALT but also the site of local long-term specific antibody production.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Virus-specific antibody responses in the D-NALT are maintained for at least 18 months after primary intranasal infection with influenza virus. Mice were sacrificed at certain time points postinfection, and virus-specific AFCs in the cervical lymph nodes (A), O-NALT (B), and D-NALT (C) were enumerated by the ELISPOT assay. Cells were pooled from four or five mice per time point. Each panel is representative of one experimental time course. Each time course was carried out three times independently with similar results. D, day; M, months.
FIG. 2
FIG. 2
Virus-specific AFC frequencies in the lung (A) and bone marrow (B) after primary intranasal infection with influenza virus. Mice were sacrificed at certain time points postinfection, and virus-specific AFCs in the lung and bone marrow were enumerated by the ELISPOT assay. Cells were pooled from four or five mice per time point. Each panel is representative of one experimental time course. Each time course was carried out three times independently with similar results. D, day; M, months.
FIG. 3
FIG. 3
Influenza virus is cleared later in the D-NALT than in the O-NALT or the lung. Influenza virus titers were determined by inoculation into the allantoic fluid cavities of 10-day-old embryonated hen eggs. HA activity was assayed 72 h later. Assays were performed in triplicate with three mice per time point, and results are the means and standard deviations from three independent experiments. EID50, 50% egg infective dose; D, day.

Similar articles

Cited by

References

    1. Asanuma H, Inaba Y, Aizawa C, Kurata T, Tamura S. Characterisation of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J Immunol Methods. 1995;187:41–51. - PubMed
    1. Asanuma H, Thompson A, Iwasaki T, Sato Y, Inaba Y, Aizawa C, Kurata T, Tamura S. Isolation and characterisation of mouse nasal-associated lymphoid tissue. J Immunol Methods. 1997;202:123–131. - PubMed
    1. Clements L M, O'Donnell S, Levine M M, Chanock R M, Murphy B R. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect Immun. 1983;40:1044–1051. - PMC - PubMed
    1. Clements L M, Murphy B R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986;23:66–72. - PMC - PubMed
    1. Eichelberger M C, Wang M, Allan W, Webster R G, Doherty P C. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J Gen Virol. 1991;72:1695–1698. - PubMed

Publication types

Substances

LinkOut - more resources